- Home
- CTNM vs LEO Comparison
CTNM vs LEO Comparison
Compare CTNM & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- LEO
- Stock Information
- Founded
- CTNM 2009
- LEO 1987
- Country
- CTNM United States
- LEO United States
- Employees
- CTNM N/A
- LEO N/A
- Industry
- CTNM
- LEO Trusts Except Educational Religious and Charitable
- Sector
- CTNM
- LEO Finance
- Exchange
- CTNM Nasdaq
- LEO Nasdaq
- Market Cap
- CTNM 453.0M
- LEO 394.9M
- IPO Year
- CTNM 2024
- LEO N/A
- Fundamental
- Price
- CTNM $17.21
- LEO $6.25
- Analyst Decision
- CTNM Strong Buy
- LEO
- Analyst Count
- CTNM 4
- LEO 0
- Target Price
- CTNM $29.25
- LEO N/A
- AVG Volume (30 Days)
- CTNM 74.8K
- LEO 200.2K
- Earning Date
- CTNM 11-06-2024
- LEO 01-01-0001
- Dividend Yield
- CTNM N/A
- LEO 4.01%
- EPS Growth
- CTNM N/A
- LEO N/A
- EPS
- CTNM N/A
- LEO 0.04
- Revenue
- CTNM N/A
- LEO N/A
- Revenue This Year
- CTNM N/A
- LEO N/A
- Revenue Next Year
- CTNM N/A
- LEO N/A
- P/E Ratio
- CTNM N/A
- LEO $152.00
- Revenue Growth
- CTNM N/A
- LEO N/A
- 52 Week Low
- CTNM $13.27
- LEO $4.98
- 52 Week High
- CTNM $22.00
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- LEO 44.12
- Support Level
- CTNM N/A
- LEO $6.11
- Resistance Level
- CTNM N/A
- LEO $6.36
- Average True Range (ATR)
- CTNM 0.00
- LEO 0.08
- MACD
- CTNM 0.00
- LEO 0.01
- Stochastic Oscillator
- CTNM 0.00
- LEO 61.54
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others.